| Term 
 | Definition 
 
        | reversibility inhibits the growth of bacteria. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | kills the susceptible bacteria. |  | 
        |  | 
        
        | Term 
 
        | Minimum Inhibitory Concentration (MIC) |  | Definition 
 
        | lowest concentration of antibiotic that results in inhibition of visible growth (i.e. colonies on a plate or turbidity in broth) under standard conditions. |  | 
        |  | 
        
        | Term 
 
        | For an antibiotic to be effective... |  | Definition 
 
        | it must reach either MIC or MBC at the site of the infection. |  | 
        |  | 
        
        | Term 
 
        | Antibiotic is bactericidal |  | Definition 
 
        | if MIC and MBC are close in value. |  | 
        |  | 
        
        | Term 
 
        | Antibiotic is bacteriostatic |  | Definition 
 
        | if the MBC is much higher than the MIC |  | 
        |  | 
        
        | Term 
 
        | Minimum bactericidal concentration (MBC) |  | Definition 
 
        | the lowest concentration of the antibiotic that kills 99.9% of the original inoculum in a given time. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | bacterial strain inhibited by in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | bacterial stain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bacterial stain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. |  | 
        |  | 
        
        | Term 
 
        | Clinical and Laboratory Standards Institute (2013) |  | Definition 
 
        | harmonized terminology database. http://login.clsi.org/HTDatabase.cfm
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pregnancy Cat. D.  Not recommended for children under 9 years or for breast feeding mothers. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | not recommended for children under 18 years (except for inhalation antrax)or breast feeding mothers. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | are no recommended for third trimester of pregnancy. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | not recommended at term of pregnancy. |  | 
        |  | 
        
        | Term 
 
        | Monthly prescribing reference |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Inhibit Cell Wall Synthesis |  | Definition 
 
        | Beta-lactams Penicillin (+/- Beta lactamase inhibitors)
 Cephalosporins (3 generations)
 Monobactams
 Carbapenems
 Glycopeptides (Vancomycin, Telovavancin)
 Fosfomycin (Manurol)
 |  | 
        |  | 
        
        | Term 
 
        | Inhibit Protein Synthesis |  | Definition 
 
        | Aminoglycosides (Gentamycin, Tobramycin, Streptomycin, Kanamycin, Amikacin) Macrolides & Ketolides (Erythromycin, Azithromicin, Clarithromycin, Telithromycin)
 Lincosamides (Clindomycin Lincomycin)
 Stretogramins (Synercid)
 Tetracyclines (Tertracycline, Moncycline, Doxycycline)
 Glycylcyclines (Tigercycline)
 Phenicals (Chloromphenicol)
 Oxazolidinones (Linezolid)
 Ansamycins (Rifampin)
 |  | 
        |  | 
        
        | Term 
 
        | Inhibit Membrane Functions |  | Definition 
 
        | Leptopeptides (Daptomycin) Polymyxin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sulfonamides (Sulfamethoxazole/Trimethaprim, Sulfisoxazole) |  | 
        |  | 
        
        | Term 
 
        | Inhibit Nucleic Acid Synthesis |  | Definition 
 
        | Fluoroquinolones (Ciprofloxacin, Levofloxacin, Moxifloxacin, Ofloxacin) Furanes (Nitrofurantoin)
 |  | 
        |  |